integMET
Home
About
Documentation
Diff Profiles
Metabolites
studies
Gragh
Metabolites
›
XEBKSQSGNGRGDW-UHFFFAOYSA-N
XEBKSQSGNGRGDW-UHFFFAOYSA-N
XEBKSQSGNGRGDW-UHFFFAOYSA-N
0 Reactome links
2 studies
2
Observed studies
2
Observed diff profiles
0
Reactome pathways
Metabolite details
Identifier
XEBKSQSGNGRGDW-UHFFFAOYSA-N
InChI Key
XEBKSQSGNGRGDW-UHFFFAOYSA-N
IUPAC name
Preferred name
XEBKSQSGNGRGDW-UHFFFAOYSA-N
INN name
—
Synonym
—
ChEBI
—
Reactome pathways
No Reactome pathways listed for this metabolite.
Observed in studies
Lipid mediators of inflammation in BALF 3-11 days after infection with influenza.
Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide
Observed in differential profiles
G1_Mock_11_day_vs_G5_PR8_11_day
Control_vs_OXPA_Treatment